| Issue |
Section |
Title |
File |
| Vol 13, No 4 (2017) |
CONGRESSES AND CONFERENCES |
Review of the Proceedings of the European Society for Medical Oncology (ESMO) 2017 Congress |
(Rus)
|
| Vol 14, No 1 (2018) |
REVIEW |
On staging of urologic cancers in accordance with the updated 8th edition of the TNM Classification |
(Rus)
|
| Vol 14, No 2 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Risk-adapted approach to prostate cancer screening |
(Rus)
(Eng)
|
| Vol 14, No 3 (2018) |
CONGRESSES AND CONFERENCES |
REVIEW OF THE ONCOLOGICAL UROLOGY PROCEEDINGS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) 2018 ANNUAL MEETING |
(Rus)
|
| Vol 14, No 4 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Impact of germline CHEK2 mutations on biochemical relapse free survival and metastasis free survival after radical treatment for patients with prostate cancer |
(Rus)
|
| Vol 15, No 1 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
The prognostic value of tumor PD-L1 status in patients with metastatic prostate cancer |
(Rus)
|
| Vol 15, No 1 (2019) |
CONGRESSES AND CONFERENCES |
Review of the proceedings of the 2019 Genitourinary Cancers Symposium of the American society of clinical oncology (ASCO GU 2019) |
(Rus)
|
| Vol 15, No 4 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Is technically complicated partial nephrectomy justified in renal cell carcinoma patients with normal contralateral kidney? |
(Rus)
|
| Vol 16, No 3 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
An interim analysis of non-interventional study of the epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia |
(Rus)
|
| Vol 18, No 2 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia |
(Rus)
|
| Vol 19, No 3 (2023) |
REVIEWS |
Nephrotoxicity of combination drug therapy in metastatic renal cancer |
(Rus)
|
| Vol 21, No 2 (2025) |
CLINICAL NOTES |
Efficacy of cabozantinib in the 1st line therapy of progressing multiple primary metachronous renal cell carcinomas: clinical observation |
(Rus)
|
